IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma.
Ru J, Lu J, Ge J, Ding B, Su R, Jiang Y, Sun Y, Ma J, Li Y, Sun J, Xu G, Tong R, Zheng S, Yang B, Wu J.
Ru J, et al. Among authors: sun j, sun y.
Cancer Lett. 2024 Jan 28;581:216495. doi: 10.1016/j.canlet.2023.216495. Epub 2023 Nov 21.
Cancer Lett. 2024.
PMID: 37993085